Are you or your loved ones suffering from advanced solid tumors?

You may be eligible to participate in a advanced solid tumors clinical trial.

Are you or your loved ones suffering from advanced solid tumors? You may be eligible to participate in a advanced solid tumors clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Solid Tumors
NCT02609230 | Phase 1 | Interventional
What you may receive

Study related treatment at no cost

Are you or your loved ones suffering from advanced solid tumors?

You may be eligible to participate in a advanced solid tumors clinical trial.

Are you or your loved ones suffering from advanced solid tumors? You may be eligible to participate in a advanced solid tumors clinical trial.

Recruiting

Male & Female

18 +

years old

This study will determine the maximum tolerated dose (MTD) and/or the recommended phase II dose (RP2D) of single agent ONC201 in patients with advanced solid tumors or multiple myeloma.

Where you'll go

Selected location

Fox Chase Cancer Center Philadelphia

Fox Chase Cancer Center Philadelphia Change

Philadelphia, PA, USA 19111-2497

Anthony Olszanski, MD 215-728-6900

Get directions | Learn more

Interested in participating?

Selected location

Fox Chase Cancer Center Philadelphia

Philadelphia, PA, USA 19111-2497

Anthony Olszanski, MD 215-728-6900


By clicking the button, you agree to the Terms and Privacy Policy.

Sign up now